Emmanuel Odame
Job title
-
Adjunct Instructor of Biological Sciences
Biological Sciences, College of Arts and Sciences
Highlight
As an Adjunct Faculty member and PhD candidate at the University of Minnesota, I specialize in the molecular mechanisms of neurovascular health. My research investigates the blood-brain and blood-retinal barriers to unlock new therapeutic targets for ocular disorders. I am committed to the ‘hands-on science' philosophy, integrating 8+ years of advanced laboratory expertise in protein biochemistry and in vivo modeling with a passion for mentoring the next generation of researchers. My work aims to move science from theoretical complexity to tangible translational impact
Started at Bethel
2026
Education
- Sichuan Agricultural University - M.S in Animal Breeding, Genetics & Reproductive Science, 2022
Biography
Emmanuel Odame is a Molecular and Neurovascular Biologist and PhD candidate at the University of Minnesota, specializing in the complex physiological barriers of the brain and retina. With over eight years of advanced research experience, Emmanuel’s work focuses on the blood-brain and blood-retinal barriers, investigating angiogenesis and the molecular drivers of retinopathies such as AMD and diabetic retinopathy.
His research integrates a sophisticated technical toolkit, including CRISPR/Cas9, RNA regulation, and protein biochemistry, with in vivo disease modeling to generate insights with translational potential. Emmanuel complements his discovery science with a rigorous focus on industry standards, including SOP development, quality control (QC), and regulatory documentation.
A committed educator and mentor, Emmanuel currently serves as an Adjunct Professor at Bethel University (2026), following a successful tenure as an Adjunct Professor at the University of St. Thomas (2025). He excels at "bridging the gap" between abstract molecular theory and hands-on laboratory application, preparing the next generation of scientists for the demands of modern R&D. Emmanuel is currently focused on leveraging his expertise in assay development and translational biology to drive innovation within the biotechnology and pharmaceutical sectors.